India Continuous Glucose Monitoring Devices Market
Description
India Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Sensors, Device/Readers, Applicators, Transmitters), By Connectivity (Bluetooth, 4G/Cellular, NFC), By Indication, By Distribution Channel, And Segment Forecasts, 2026 - 2033
India Continuous Glucose Monitoring Devices Market Summary
The India continuous glucose monitoring devices market size was estimated at USD 45.92 million in 2025 and is expected to reach USD 105.67 million in 2033, growing at a CAGR of 11.56% from 2026 to 2033. A shift toward proactive diabetes management and the adoption of digital health tools are fueling demand.
The rising geriatric population and sedentary lifestyles contribute to the disease burden, necessitating the development of advanced monitoring solutions. Furthermore, expanding healthcare infrastructure, the availability of CGM devices through e-commerce and pharmacies, and collaborations between global players and Indian healthcare providers enhance accessibility. Technological advancements like sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.
India, a key country in the International Diabetes Federation (IDF) South-East Asia region, is grappling with a growing diabetes crisis. Of the 589 million global cases of diabetes, 107 million are in this region. By 2050, the regional number is expected to rise to 185 million. India alone has a staggering 89.8 million adult diabetes cases, with a 10.5% adult prevalence rate among its 947 million adult population.
To raise awareness and promote better care, World Diabetes Day is observed every year on November 14. The 2024 theme, “Breaking Barriers, Bridging Gaps,” emphasizes collaborative action to improve diagnosis, treatment, and equal access to care. It also encourages health systems to address care disparities and foster inclusion.
Diabetes is a chronic disease caused by insufficient insulin production or improper insulin usage, leading to high blood glucose levels. Left uncontrolled, it can damage vital organs and cause severe complications, including heart disease, kidney failure, blindness, and nerve damage. Early symptoms include frequent urination, thirst, fatigue, blurred vision, and unexplained weight loss.
India Continuous Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the India continuous glucose monitoring (CGM) devices market report based on product, connectivity, indication, and distribution channel:
India Continuous Glucose Monitoring Devices Market Summary
The India continuous glucose monitoring devices market size was estimated at USD 45.92 million in 2025 and is expected to reach USD 105.67 million in 2033, growing at a CAGR of 11.56% from 2026 to 2033. A shift toward proactive diabetes management and the adoption of digital health tools are fueling demand.
The rising geriatric population and sedentary lifestyles contribute to the disease burden, necessitating the development of advanced monitoring solutions. Furthermore, expanding healthcare infrastructure, the availability of CGM devices through e-commerce and pharmacies, and collaborations between global players and Indian healthcare providers enhance accessibility. Technological advancements like sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.
India, a key country in the International Diabetes Federation (IDF) South-East Asia region, is grappling with a growing diabetes crisis. Of the 589 million global cases of diabetes, 107 million are in this region. By 2050, the regional number is expected to rise to 185 million. India alone has a staggering 89.8 million adult diabetes cases, with a 10.5% adult prevalence rate among its 947 million adult population.
To raise awareness and promote better care, World Diabetes Day is observed every year on November 14. The 2024 theme, “Breaking Barriers, Bridging Gaps,” emphasizes collaborative action to improve diagnosis, treatment, and equal access to care. It also encourages health systems to address care disparities and foster inclusion.
Diabetes is a chronic disease caused by insufficient insulin production or improper insulin usage, leading to high blood glucose levels. Left uncontrolled, it can damage vital organs and cause severe complications, including heart disease, kidney failure, blindness, and nerve damage. Early symptoms include frequent urination, thirst, fatigue, blurred vision, and unexplained weight loss.
India Continuous Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the India continuous glucose monitoring (CGM) devices market report based on product, connectivity, indication, and distribution channel:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Sensors
- Transmitters
- Device/Readers
- Applicators
- Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
- Bluetooth
- 4G/Cellular
- NFC (Near Field Communication)
- Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Type 1 Diabetes
- Type 2 Diabetes
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmacies
- E-commerce
- Others
Table of Contents
125 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. India CGM Devices Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. India CGM Devices Market Analysis Tools
- 3.4.1. Porter’s Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- Chapter 4. India CGM Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. India Continuous Glucose Monitoring Devices Market Product Movement Analysis
- 4.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2025 to 2033 (USD Million)
- 4.4. Sensors
- 4.4.1. Sensors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Transmitters
- 4.5.1. Transmitters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Device/Readers
- 4.6.1. Device/Readers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Applicators
- 4.7.1. Applicators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. India CGM Devices Market: Connectivity Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. India Continuous Glucose Monitoring Devices Market Connectivity Movement Analysis
- 5.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Connectivity, 2025 to 2033 (USD Million)
- 5.4. Bluetooth
- 5.4.1. Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5. 4G/Cellular
- 5.5.1. 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.6. NFC (Near Field Communication)
- 5.6.1. NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 6. India CGM Devices Market: Indication Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. India Continuous Glucose Monitoring Devices Market Indication Movement Analysis
- 6.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Indication, 2025 to 2033 (USD Million)
- 6.4. Type 1 Diabetes
- 6.4.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Type 2 Diabetes
- 6.5.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. India CGM Devices Market: Distribution Channel Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. India Continuous Glucose Monitoring Devices Market Distribution Channel Movement Analysis
- 7.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Distribution Channel, 2025 to 2033 (USD Million)
- 7.4. Pharmacies
- 7.4.1. Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. E-commerce
- 7.5.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Others
- 7.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.4.1. Abbott Laboratories
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Medtronic PLC
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. SugarFit
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Health Arx Technologies Pvt. Ltd.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Healthify
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. DrStore Healthcare Services India Pvt Ltd
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. GoodFlip
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Actofit
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. AmiciCare
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
